Delivery Order 75N95022D00023-75N95024F00003
Award Date
7/19/24
Potential Completion Date
7/18/26
Potential Value
$5.7M
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541512 - Computer Systems Design Services
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Germantown, MD 20875, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of 75N95022D00023|75N95024F00002, was made by the National Institute of Neurological Disorders and Stroke (NINDS) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The $13,049,822.20 contract is for the cGMP manufacture of VHCA8* for the treatment of pain. It is a delivery order under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for...
This is a $3,500 firm-fixed-price delivery order awarded to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health. The order is under the NIAID's Diagnostics Pre-Clinical Services Program Indefinite Delivery Vehicle (IDV), which has a total ceiling value of $24 million. ABL, a foreign-owned, for-profit manufacturer, is providing a range of preclinical development services to support...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer. The $2,152,834.00 contract is for preclinical development support services, including biologics manufacturing, testing, storage, shipping, and quality assurance. ABL has been awarded over $35...
The Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $6,045,215 delivery order to Advanced Bioscience Laboratories, Inc. under the prime contract vehicle "Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders." This delivery order is for the manufacture and preclinical testing of site blocking oligonucleotides...
This federal contract award from the National Institutes of Health (NIH) was issued to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The $2,862.40 contract is for an "ENZYME IMMUNOASSAY" and was awarded on April 24, 2015 with a completion date of May 8, 2015. ABL is a leading contract research and manufacturing organization that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The company has...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $6,633.90, does not have a set-aside designation. ABL is a contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. Under this contract, ABL will provide a range of...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious...
This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $213,045,738.00, is for preclinical development services to support infectious disease research and product development initiatives. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants,...
This is a prime contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) on September 20, 2017. The contract has a potential value of $2,044,103.00 and is a Delivery Order for NIAID Preclinical Development Support services. The contract has a completion date of December 31, 2022 and is not set-aside. ABL is a contract research and...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for $1,812,395.46 and provides for the manufacture and characterization of vaccines and other biologics. The contract does not have a set-aside designation. ABL is a foreign-owned, for-profit organization that specializes in the development of gene...